Nurix Therapeutics, Inc.
NRIX
$10.55
$0.313.03%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.29% | 111.73% | 73.09% | 57.60% | -11.96% |
| Total Receivables | 162.50% | 87.50% | -71.43% | -40.00% | -33.33% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 93.05% | 22.21% | 14.20% | -17.34% | -38.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 124.61% | 109.60% | 70.20% | 55.24% | -12.96% |
|
|
|||||
| Total Current Assets | 124.61% | 109.60% | 70.20% | 55.24% | -12.96% |
| Net Property, Plant & Equipment | -5.00% | -4.28% | 72.41% | 66.66% | 64.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 53.90% | -14.06% | -17.30% | -14.20% | -10.52% |
| Total Assets | 96.70% | 88.23% | 66.65% | 45.75% | -15.53% |
|
|
|||||
| Total Accounts Payable | 41.89% | 79.38% | 79.15% | -37.83% | 5.13% |
| Total Accrued Expenses | 48.55% | 42.55% | 24.82% | 28.03% | 90.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.18% | 7.01% | 22.21% | 42.11% | 31.57% |
| Total Finance Division Other Current Liabilities | -26.73% | -14.33% | 50.63% | 6.97% | 19.86% |
| Total Other Current Liabilities | -26.73% | -14.33% | 50.63% | 6.97% | 19.86% |
| Total Current Liabilities | 2.70% | 10.23% | 40.33% | 11.79% | 35.06% |
|
|
|||||
| Total Current Liabilities | 2.70% | 10.23% | 40.33% | 11.79% | 35.06% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.52% | -12.26% | 679.33% | 455.75% | 327.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -29.90% | -41.79% | 191.50% | 163.39% | 31.93% |
| Total Liabilities | -6.81% | -8.22% | 83.85% | 54.72% | 49.76% |
|
|
|||||
| Common Stock & APIC | 68.80% | 69.57% | 43.13% | 37.63% | 5.08% |
| Retained Earnings | -35.52% | -35.50% | -35.17% | -35.39% | -32.75% |
| Treasury Stock & Other | 164.57% | 122.90% | 128.01% | 92.91% | 89.22% |
| Total Common Equity | 184.99% | 162.85% | 61.18% | 42.62% | -38.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 184.99% | 162.85% | 61.18% | 42.62% | -38.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 184.99% | 162.85% | 61.18% | 42.62% | -38.42% |
|
|
|||||